Related Experiment Video
Updated: Apr 15, 2026
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Exploring the association between serum vitamins and CAP-defined hepatic steatosis in lean and non-lean adults with
Caijuan Hong1, Lili Jiang1, Lulu Xia1
1Hangzhou Linping District Integrated Traditional Chinese and Western Medicine Hospital, Hangzhou, Zhejiang, China.
Background:
Non-alcoholic fatty liver disease (NAFLD) is highly prevalent worldwide, yet the role of serum vitamins in hepatic fat accumulation, particularly across lean and non-lean individuals, remains incompletely understood. This study evaluated associations between serum levels of vitamins A, C, D, and E and the degree of CAP-defined hepatic steatosis in lean and non-lean adults.
Methods:
Data from the 2017-2018 NHANES were analyzed. Weighted multivariable linear regression was performed in lean and non-lean adults to assess the associations between serum vitamin levels and CAP-defined hepatic steatosis, using unadjusted, demographic-adjusted, and fully adjusted models.
Results:
No significant linear associations were observed between serum vitamin levels and the degree of hepatic steatosis in lean adults. A nonlinear association with serum vitamin C was observed, indicating a threshold effect. The association between vitamin C and the degree of liver fat accumulation also varied by diabetes status. In non-lean adults, serum vitamin C consistently showed an inverse association with CAP-defined hepatic steatosis (Model 2: β = -0.16, 95% CI: -0.25 to -0.07), as did vitamins A (β = -6.34, 95% CI: -10.43 to -2.25) and D (β = -0.13, 95% CI: -0.21 to -0.04).
Conclusion:
Higher serum levels of vitamins A, C, and D were associated with lower CAP-defined hepatic steatosis in non-lean adults, while a nonlinear relationship involving vitamin C was observed in lean individuals. Further studies are needed to confirm these findings.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:30Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
01:24Serum Studies: Renal Function Tests